1. Scrip
  2. >>Partnered Content

Japan’s Strengths As A Clinical Study Location And Why Selecting The Right Partner Is Crucial

Infographic: Advancing Drug Development in Oncology
A2 Healthcare

Japan represents one of the world’s largest single-country pharma markets, but as of 2020, 72% of drugs approved for use in Europe and the United States were not approved in Japan.

Read this free article now to:

  • Discover the scope of opportunities available in the Japanese market.
  • Uncover the truth behind several misapprehensions about drug development in Japan.
  • Examine the benefits of conducting clinical research in Japan.
  • Explore how effective collaborations between CROs and biotechs can ease the entry for drugs into Japan.

Download the article: Japan’s Strengths As A Clinical Study Location And Why Selecting The Right Partner Is Crucial

More from Partnered Content

Sponsored by:

Oncology R&D trends at a glance

Access key stats from biotechs on the latest trends impacting oncology R&D, including therapeutic pipelines and clinical trial challenges, AI/ML, and a future outlook on innovation.

Sponsored by:

Infographic: Advancing Drug Development in Oncology

Gain exclusive insights into the biggest challenges biotechs face in oncology and uncover the latest opportunities to accelerate drug development.

Sponsored by:

Japan’s Strengths As A Clinical Study Location And Why Selecting The Right Partner Is Crucial

Learn about the critical role the right CRO plays in successfully navigating the significant drug development opportunities in Japan.

Sponsored by:

Roundtable Report: Keeping Pace with CGT Innovation

CGTs are among the fastest-growing areas in therapeutics - explore the key strategies driving long-term commercial success across the entire product lifecycle.

More from Scrip

Sponsored by:

Making medicines more affordable to the NHS

Delve into the challenges facing the NHS, from rising medicine costs to supply shortages, and how generics and branded generics can provide solutions for a more sustainable healthcare system

Sponsored by:

Oncology R&D trends at a glance

Access key stats from biotechs on the latest trends impacting oncology R&D, including therapeutic pipelines and clinical trial challenges, AI/ML, and a future outlook on innovation.

Sponsored by:

Infographic: Advancing Drug Development in Oncology

Gain exclusive insights into the biggest challenges biotechs face in oncology and uncover the latest opportunities to accelerate drug development.

Sponsored by:

Japan’s Strengths As A Clinical Study Location And Why Selecting The Right Partner Is Crucial

Learn about the critical role the right CRO plays in successfully navigating the significant drug development opportunities in Japan.